3D Tissue Models

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors Review type Summary Keywords File filename File mime type
1. 2011 Upregulation of Fanconi Anemia DNA repair genes in melanoma compared with non-melanoma skin cancer Journal of Investigative Dermatology, 23 June 2011; doi: 10.1038/jid.2011.181
2. 2011 Emerging metabolic targets in cancer therapy Frontiers in Bioscience, 16:1844-60
3. 2011 Over-expression of the PAEP gene is regulated by MITF in human melanoma The Ochsner Journal, In Press
4. 2010 Resection and reconstruction of a solitary sternal metastasis after mastectomy for breast cancer: A case report and review of the literature Contemporary Oncology, 2(4)
5. 2010 The Familial Atypical Multiple Mole Melanoma-Pancreatic Carcinoma (FAMMM-PC) Syndrome “Genetically Based Cancer Syndromes”, edited by C. Neal Ellis, M.D
6. 2010 Genetic Breast Cancer Syndromes “Genetically Based Cancer Syndromes”, edited by C. Neal Ellis, M.D
7. 2010 MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptoptic Bcl-2 antagonist killer 1 (Bak1) expression Journal of Biological Chemistry, 285(28): 21496-507
8. 2010 Treatment options for patients with Stage III and IV melanoma. Part II: Experimental treatments for stage III/IV or refractory/recurrent melanoma. Contemporary Oncology, 1(2): 28-36
9. 2010 Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma BMC Medicine, Feb 17th, 8(1)
10. 2010 Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1 Oncology, 78(1): 75-86
11. 2010 A personalized microRNA microarray normalization method using a logistic regression model Bioinformatics, 26(2):228-34
12. 2010 Functional characterization of the progestagen-associated endometrial protein gene in human melanoma Journal of Cellular and Molecular Medicine, 14(6B): 1432-42
13. 2010 Cystatin E/M suppresses legumain activity and invasion of human melanoma cells BMC Cancer, Jan 15th, 10(1): 17
14. 2010 Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol Molecular Cancer, 9:33
15. 2010 From the Editor’s Desk The Ochsner Journal, 10(2): 55
16. 2010 Amplifying TLR-MyD88 signals within tumor-specific T-cells enhances anti-tumor activity to sub-optimal levels of weakly-immunogenic tumor-antigens Cancer Research, 70(19):7442-54
17. 2010 The epidemiology, prevention, and detection of melanoma The Ochsner Journal, 10(2): 56-65
18. 2010 MicroRNA in melanoma The Ochsner Journal, 10(2): 83-92
19. 2009 Treatment options for patients with Stage III and IV melanoma. Part I: A look at existing neoadjuvant and adjuvant treatments Contemporary Oncology, 1(2): 53-63
20. 2009 Research Highlights: Recent results and advances in the immunotherapy of melanoma Immunotherapy, 1(6), 921-924
21. 2009 Epigenetics in human melanoma Cancer Control, 16(3): 200-18
22. 2009 The hedgehog pathway transcription factor, GLI1, promotes malignant behavior of cancer cells by up-regulating osteopontin Journal of Biological Chemistry, 284 (34): 22888-97
23. 2009 Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma Clinical and Experimental Metastasis, 26(7): 739-749
24. 2009 The 14-3-3-σ gene promoter is methylated in both human melanocytes and melanoma. BMC Cancer, 9: 162
25. 2009 Carcinosarcoma of the breast: A report of two cases and review of the literature Cases Journal, 2(1): 15
26. 2009 Current concepts in biobanking: Development and implementation of a tissue repository Frontiers in Biosciences, June 1st, S1(4), 188-193
27. 2008 The surgical management of breast cancer metastases “Breast Cancer Metastasis”, edited by Oystein Fodstad M.D., Ph.D., Wen Jiang M.B., Ph.D., Robert Mansel M.S., F.R.C.S., C.B.E
28. 2008 The impact of genomics in understanding human melanoma progression and metastasis Cancer Control, 15(3), 202-215
29. 2008 Activated Stat-3 in Melanoma Cancer Control, 15(3), 196-101
30. 2008 Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high risk melanoma treated with adjuvant GM-CSF Journal of Clinical Oncology, 26(19): 3235-3241
31. 2008 Genetic and Molecular Interrogation of Human Melanoma Yields a Metastatic Signature and Transition Point of Progression and Metastasis BMC Medical Genomics, April 28th, 1-13,
32. 2008 Full-thickness Grafts Procured from Skin Overlying the Sentinel Lymph Node Basin; Reconstruction of Primary Cutaneous Malignancy Excision Defects Annals of Surgical Oncology, 15(6): 1733-40
33. 2008 Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts Cancer Genomics and Proteomics 5(1), 1-35
34. 2008 Comparative methodologies of regulatory T-cell depletion in a murine melanoma model Journal of Immunological Methods, 20;333(1-2):167-79
35. 2008 The significance of sentinel lymph node micrometastases in human breast cancer. Journal of the American College of Surgeons (JACS), 206(2), 261-268
36. 2008 Successful removal of a giant intrathoracic lipoma: A case report and review of the literature Cases Journal, 1(1):87
37. 2008 Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma Journal of Clinical Oncology, 20;26(36): 5896-903
38. 2008 Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling Pigment Cell and Melanoma Research, 21(5), 545-558
39. 2007 Immunotherapy of Melanoma. Expert Opinion in Biologic Therapy, 7(3), 345-358
40. 2007 Roscovitine inhibits differentiation and invasion in a 3-dimensional skin reconstruction model of metastatic melanoma Molecular Cancer Research, 5(2), 145-151
41. 2007 The surgical management of cutaneous melanoma Giornale Italiano Di Dermatologia E Venerologia. 142, 171-195
42. 2007 Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma Annals of Surgical Oncology, 14(4), 1416-1423
43. 2007 Letter to the Editor in response to “Payformance a Slap in the Face: Will Surgeons Respond?”, General Surgery News
44. 2006 Recent Advances in Melanoma Frontiers in Bioscience, January 1st, 11, 1-14
45. 2006 Association of insulin-like growth factor binding protein (IGFBP-3) expression with melanoma progression Molecular Cancer Therapeutics, 5(12), 3078-3084
46. 2006 Current Surgical Management of Melanoma Expert Review of Anti-Cancer Therapy, 6(11), 1569-1583
47. 2006 Letter to the Editor in response to “Dropping out of Managed Care”, General Surgery News
48. 2006 Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model Journal of Immunotherapy, July/August 29(4), 381-87
49. 2006 Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: A multi-institutional study Annals of Surgical Oncology, 13(6), 809-16
50. 2006 Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells Cancer Immunology/Immunotherapy, October, 55(10), 1238-46
51. 2006 Wnt5a regulates melanoma antigen recognized by T-cells-1 (MART-1), a predominant antigen in melanoma cells Clinical Immunology, 119(1), S90
52. 2006 Management of the patient with cutaneous melanoma “Case Files: General Surgery”, edited by Eugene Toy M.D. and Terrence Liu M.D
53. 2005 Current Immunotherapy of Melanoma Clinical and Applied Immunology Reviews (CAIR), 5: 111-132
54. 2005 Older adults require routine skin screening Going Places,
55. 2005 Sentinel node biopsy for thin melanomas (<1.00 mm): Which patients should be considered Cancer Control, 12(4), 230-235
56. 2005 Cutaneous Melanoma: Methods of biopsy and definitive surgical excision Dermatologic Therapy, 18(5):387-93
57. 2005 Complications of soft tissue surgery “Complications in Surgery”, edited by Mulholland and Doherty
58. 2005 DC-based vaccines gaining ground Dermatology Times,
59. 2004 Isolation and culture of melanoma cell lines Methods in Molecular Medicine, 88: 93-100
60. 2004 Letter to the editor The Breast Journal, 10(3), 267
61. 2004 Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region Pigment Cell Research, 17: 525-53
62. 2003 Altered expression of tumor antigens “Mechanisms of Tumor Escape from the Immune Response”, edited by Ochoa A. (Taylor and Francis).
63. 2003 The isolation and culture of melanoma cell lines In “Cancer Cell Culture”, edited by Simon Langdon MA, Ph.D
64. 2002 Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells American Journal of Pathology, 160 (2): 521-528
65. 2002 The management of complex tracheobronchial fistulas and strictures: One surgeon’s experience International Surgery, 87: 114-119
66. 2002 The utility of fine needle aspiration biopsy for the prospective analysis of patients undergoing therapy for metastatic melanoma “Melanoma Techniques and Protocols: Molecular Diagnosis, Treatment, and Monitoring”, edited by Brian Nickoloff, M.D., Ph.D
67. 2002 Open Roux-en-Y gastric bypass for the morbidly obese in the era of laparoscopy. The American Journal of Surgery, 184: 611-616
68. 2002 Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: Its role in extracellular matrix formation and tumor metastasis. Journal of Experimental Medicine, 195(11): 1397-1406
69. 2001 Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials Cancer Cytopathology, 93: 409-14
70. 2001 Short term kinetics of tumor antigen expression in response to vaccination Journal of Immunology, 167(3): 1809-20
71. 2001 Evaluation of response to vaccination trials: advances, pitfalls and paradoxes “The Biology of Melanoma”. Atzori F. Ed. (from the 1st International Symposium on Melanoma. Rome
72. 2000 Expansion of tumor/T-cell pairs from fine needle aspirates of melanoma metastases Journal of Immunology, 164 (1): 495-504
73. 2000 Tumors that undergo complete response experience preferential decrease in expression of melanoma differentiation antigens Surgical Forum, Volume 51
74. 2000 A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12 Journal of Immunology, 164 (8): 4382-92
75. 2000 Antigen loss variants in melanoma: Potential induction by interferon-gamma Pigment Cell Research, (13): 210
76. 2000 Threshold levels of gene expression of the melanoma antigen, gp100, correlates with tumor cell recognition by cytotoxic T-lymphocytes International Journal of Cancer, 86: 818-826
77. 2000 Tyrosinase immunoreactivity in fine needle aspiration samples of metastatic malignant melanoma: Fixation methods yield variable results Cancer Cytopathology, 90:252-7
78. 2000 Functional analysis of antigen-specific T-lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens Journal of Immunology, 163 (12): 6867-6875,
79. 1999 Development and characterization of melanoma cell lines established by fine needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma Cancer Detection and Prevention, 23 (5): 387-396
80. 1999 Immune selection after antigen-specific immunotherapy of melanoma Surgery, 126 (2): 112-120
81. 1999 Threshold levels of gene expression of the melanoma antigen, gp100, determine tumor cell recognition by cytotoxic T-lymphocytes Surgical Forum, Volume 50
82. 1999 Pancreaticoduodenectomy for chronic pancreatitis: A case report and literature review Hepatogastroenterology, 46 (27): 2005-2010
83. 1998 Advances in the early detection, diagnosis, and staging of pancreatic cancer. Surgical Oncology, 6 (3): 157-169
84. 1998 Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination Journal of Immunology, 161: 4183-4194
85. 1998 Impact of biotechnology on predictive oncology and therapy Investigational Drugs Journal, 1 (7): 42-46
86. 1996 Evidence of gender bias in patients undergoing flexible sigmoidoscopy. Cancer Detection and Prevention, 21 (2): 141-147
87. 1996 Vascular complications following femoral artery catheterization in burn patients. Journal of Trauma, 41(5): 904-905
88. 1995 Clostridium difficile osteomyelitis in a patient with a traumatic leg injury Infections in Medicine, 12(8): 378-380
89. 1995 Interleukin-1 receptor antagonist decreases the severity of acute experimental pancreatitis Surgery, 117: 648-655
90. 1994 Rapid elevation of systemic cytokines during acute pancreatitis and their origination within the pancreas Surgical Forum, 45: 148-150
91. 1990 Separation of 5’-dimethoxytrityl 2’-deoxynucleoside-3’-o-methylphosphonamidite diastereomers by normal phase chromatography. Tetrahedron Letters, 31(26): 3673-3676

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.